# Prevalence of Wild Type ATTR

> **NCT03966105** · — · COMPLETED · sponsor: **Oncology Institute of Southern Switzerland** · enrollment: 94 (actual)

## Conditions studied

- Wild-type Transthyretin Amyloidosis

## Interventions

- **DIAGNOSTIC_TEST:** HE and Congo red staining

## Key facts

- **NCT ID:** NCT03966105
- **Lead sponsor:** Oncology Institute of Southern Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-01
- **Primary completion:** 2021-10-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2023-03-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03966105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03966105, "Prevalence of Wild Type ATTR". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03966105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*